Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis

Annals of the Rheumatic Diseases

Volumn 72, Issue 4, 2013, Pages 473-475

  Cutolo, Maurizio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ANTINUCLEAR ANTIBODY; AROMATASE; AROMATASE INHIBITOR; DOUBLE STRANDED DNA ANTIBODY; INTERLEUKIN 1; INTERLEUKIN 6; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D;

ADJUVANT THERAPY; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; BREAST CANCER; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE COURSE; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; EDITORIAL; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; LUNG TUBERCULOSIS; MOLECULAR DYNAMICS; MYCOBACTERIUM TUBERCULOSIS; MYOSITIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RHEUMATIC DISEASE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEASONAL VARIATION; SUN EXPOSURE; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

FEMALE; HUMANS; MALE; MYOSITIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84874429392     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202538     Document Type: Editorial

References (38)

1. Holick MF. Evidence-based D-bate on health benefits of vitamin D revisited. Dermatoendocrinol 2012;4:183-90.
2. Cutolo M, Pizzorni C, Sulli A. Vitamin D endocrine system involvement in autoimmune rheumatic diseases. Autoimmun Rev 2011;11:84-7.
3. Cutolo M, Plebani M, Shoenfeld Y, et al. Vitamin D endocrine system and the immune response in rheumatic diseases.. Vitam Horm 2011;86:327-51.
4. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004;229:1136-42. (Pubitemid 39602256)
5. Cutolo M, Otsa K, Paolino S, et al. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann Rheum Dis 2009;68:446-7.
6. Haque UJ, Bartlett SJ. Relationships among vitamin D, disease activity, pain and disability in rheumatoid arthritis. Clin Exp Rheumatol 2010;28:745-7.
7. Gopinath K, Danda D. Supplementation of 1, 25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial. Int J Rheum Dis 2011;14:332-9.
8. Azali P, Barbasso Helmers S, Kockum I, et al. Low serum levels of vitamin D in idiopathic inflammatory myopathies. Ann Rheum Dis 2013;72:512-6.
9. Ritterhouse LL, Crowe SR, Niewold TB, et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011;70:1569-74.
10. Prietl B, Pilz S, Wolf M, et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases? Isr Med Assoc J 2010;12:136-9.
11. Mok CC, Birmingham DJ, Ho LY, et al. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus 2012;21:36-42.
12. Terrier B, Derian N, Schoindre Y, et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther 2012;14:R22.
13. Li Wenli, Zhang Rui, Zhang Kuo, et al. Reduced vitamin D levels are associated with autoimmune response in tuberculosis patients. Ann Rheum Dis 2012;71:790.
14. Décard BF, Von Ahsen N, Grunwald T, et al. Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis. J Neurol Neurosurg Psychiatry 2012;83:1170-3.
15. Pender MP. CD8+ T-Cell Deficiency, Epstein-Barr virus infection, vitamin D deficiency, and steps to autoimmunity: a unifying hypothesis. Autoimmune Dis 2012;2012:189096.
16. Fares A. Seasonality of tubercolosis. J Glob Infect Dis 2011;3:46-55.
17. Realegeno S, Modlin RL. Shedding light on the vitamin D-tuberculosis-HIV connection. Proc Natl Acad Sci USA 2011;108:18861-2.
18. Coussens AK, Wilkinson RJ, Hanifa Y, et al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc Natl Acad Sci USA 2012;109:15449-54.
19. Cutolo M, Otsa K, Laas K, et al. Circannual vitamin D serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol 2006;24:702-4. (Pubitemid 46138805)
20. Costenbader KH, Chang SC, Laden F, et al. Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch Intern Med 2008;168:1664-70.
21. Arkema EV, Hart JE, Bertrand KA, et al. Exposure to Ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses' Health Study. Ann Rheum Dis 2013;72:506-11.
22. Mouterde G, Lukas C, Logeart I, et al. Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis. Ann Rheum Dis 2011;70:1251-6.
23. Cutolo M. Rheumatoid arthritis: circadian and circannual rhythms in RA. Nat Rev Rheumatol 2011;7:500-2.
24. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003;89:552-72. (Pubitemid 36592083)
25. Birmingham DJ, Hebert LA, Song H, et al. Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus 2012;21:855-64.
26. Datta P, Bogh MK, Olsen P, et al. Increase in serum 25-hydroxyvitamin-D (3) in humans after solar exposure under natural conditions compared to artificial UVB exposure of hands and face. Photochem Photobiol Sci 2012;11:1817-24.
27. Aubin F. Mechanisms involved in ultraviolet light-induced immunosuppression. Eur J Dermatol, 2003;13:515-23. (Pubitemid 38030789)
28. Norval M. Effects of solar radiation on the human immune system. J Photochem Photobiol 2001;63:28-40. (Pubitemid 33040720)
29. Cutolo M. Solar light effects on onset/relapses and circannual/circadian symptomatology in rheumatoid arthritis. Clin Exp Rheumatol 2003;21:148-50. (Pubitemid 36519556)
30. Sasano H, Miki Y, Nagasaki S, et al. In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology. Pathol Int 2009;59:777-89.
31. Villaggio B, Soldano S, Cutolo M. Vitamin D modulates aromatase expression in human macrophages and downregulates proinflammatory cytokine production via ERK/MAPK signaling. Ann Rheum Dis 2012;71(suppl 1):A75.
32. Villaggio B, Soldano S, Cutolo M. 1, 25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. Clin Exp Rheumatol 2012;30:934-8.
33. Cutolo M, Sulli A, Straub RH. Estrogen metabolism and autoimmunity. Autoimmun Rev 2012;11:A460-4.
34. Folomeev M, Dougados M, Beaune J, et al. Plasma sex hormones and aromatase activity in tissues of patients with systemic lupus erythematosus. Lupus 1992;1:191-5.
35. Capellino S, Montagna P, Villaggio B, et al. Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia. Clin Exp Rheumatol 2008;26:903-9.
36. Cutolo M. The challenges of using vitamin D in cancer prevention and prognosis. Isr Med Assoc J 2012;14:637-9.
37. Krishnan AV, Swami S, Peng L, et al. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 2010;5:32-4.
38. Bosland MC, Mahmoud AM. Hormones and prostate carcinogenesis: androgens and estrogens. J Carcinog 2011;10:33-7.